Results 171 to 180 of about 525,774 (351)

Contraindicated drug–drug interactions and associated adverse drug reactions in an observational cohort study of 4543 paediatric hospitalized patients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background and Purpose Drug–drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off‐label medications, and dosing regimens often extrapolated from adult data.
Emilie Laval, Sylvain Goutelle, Inesse Boussaha, Xavier Dode, Yanis Mimouni, Kim An Nguyen, Behrouz Kassai   +6 more
wiley   +1 more source

Cardiac arrest as the initial presentation of thyrotoxicosis in a young woman. [PDF]

Endocrinol Diabetes Metab Case Rep
Siqueira Tavares de Melo MH, Barnett MJL, Rego MLM, Isaacs E, Desta E, Rivadeneira A.   +5 more
europepmc   +1 more source

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

British Journal of Clinical Pharmacology, EarlyView.
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber, Sophie‐Charlotte Bartel, Michael Boch, Christoph Rosen, Michael Bodmer, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E. Beeler   +7 more
wiley   +1 more source

Empowering congenital heart disease treatment: Physical activity prescription. The Italian proposal. [PDF]

Int J Cardiol Congenit Heart Dis
Sarubbi B, Marzullo R, Cammarano M, Abbate M, Orlando A, Turchetta A, Zeppilli P, Italian Federation of Sports Medicine, Italian Society of Sports Cardiology, with the collaboration of Italian Association of Hospital Cardiologists and Italian Society of Cardiology.   +9 more
europepmc   +1 more source

Calcium Signaling and Cardiac Arrhythmias.

Circulation Research, 2017
A. Landstrom, D. Dobrev, X. Wehrens
semanticscholar   +1 more source

The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to correlate potential links between the suspected adverse drug reaction (ADR) profile of licensed nonsteroidal androgen receptor antagonists (NSARA) with their unique chemical properties and known off‐target polypharmacology. Methods Physicochemical and polypharmacology data were curated from the Electronic Medicines Compendium ...
Simrit Dhillon, Albert A. Antolin, Alan M. Jones   +2 more
wiley   +1 more source

Identification of a SARS-CoV-2 virus-encoded small non-coding RNA in association with the neurological disorders in COVID-19 patients

Signal Transduction and Targeted Therapy, 2022
Qian Zhao, Qiong Wang, Bing Zhao, Yixing Wang, Jinhui Lü, Yuefan Guo, Xiaoping Zhu, Lu Qian, Shanshan Yu, Lipeng Hao, Zhongmin Liu, Zuoren Yu   +11 more
doaj   +1 more source

The Use of Digital Devices in the Management of Athletes with Paroxysmal Arrhythmias During Exercise-A Case Series. [PDF]

J Clin Med
Kłopotowski M, Derejko P, Małek Ł.
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Incidence of Papaverine-Induced Ventricular Arrhythmias. [PDF]

J Am Heart Assoc
Corradetti S, Munhoz D, Kodeboina M, Mahendiran T, Bermpeis K, Gallinoro E, Mizukami T, Hausmann R, De Bruyne B, Wilgenhof A, Collet C.   +10 more
europepmc   +1 more source